BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rogers ME, Balistreri WF. Cascade of care for children and adolescents with chronic hepatitis C. World J Gastroenterol 2021; 27(12): 1117-1131 [PMID: 33828389 DOI: 10.3748/wjg.v27.i12.1117]
URL: https://www.wjgnet.com/1007-9327/full/v27/i12/1117.htm
Number Citing Articles
1
Jonathan R. Honegger, Charitha Gowda. Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in childrenCurrent Opinion in Infectious Diseases 2022; 35(5): 468 doi: 10.1097/QCO.0000000000000856
2
Megan Rose Curtis, Catherine Chappell. Evidence for Implementation: HIV/HCV Coinfection and PregnancyCurrent HIV/AIDS Reports 2023; 20(1): 1 doi: 10.1007/s11904-022-00643-9
3
Maria Pokorska-Śpiewak, Anna Dobrzeniecka, Małgorzata Aniszewska, Magdalena Marczyńska. Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years—Results of the POLAC ProjectJournal of Clinical Medicine 2021; 10(18): 4176 doi: 10.3390/jcm10184176
4
Lucie Hozáková, Barbora Vokatá, Tomáš Ruml, Pavel Ulbrich. Targeting the Virus Capsid as a Tool to Fight RNA VirusesViruses 2022; 14(2): 174 doi: 10.3390/v14020174
5
Jinling Dong, Tiantian Wu, Ying Zhang, Zhihong Xie, Jie He. Transcriptome and MicroRNAs Profiling Analysis of Huh7.5.1 Cells in Response to Hepatitis C Virus InfectionHepatitis Monthly 2021; 21(8) doi: 10.5812/hepatmon.118724
6
Chen Wang, Weiran Qi, Ting Yang, Lirui Jiao, Qiushi Chen, Ke Huang, Fengyun Yu, Pascal Geldsetzer, Till Bärnighausen, Simiao Chen. The care cascade of chronic obstructive pulmonary disease in China: a cross-sectional study of individual-level data at enrolment into the national ‘Happy Breathing’ ProgrammeeClinicalMedicine 2024; 74: 102597 doi: 10.1016/j.eclinm.2024.102597
7
Maria Pokorska-Śpiewak, Anna Dobrzeniecka, Magdalena Marczyńska. One-Year Outcomes after Ledipasvir/Sofosbuvir Treatment of Chronic Hepatitis C in Teenagers with and without Significant Liver Fibrosis—A Case Series ReportViruses 2021; 13(8): 1518 doi: 10.3390/v13081518
8
Jessica Tuan, Adaora Okoli, Onyema Ogbuagu. Pharmacokinetic evaluation of sofosbuvir/velpatasvir for the treatment of Chronic Hepatitis C in pediatrics aged 3 and olderExpert Opinion on Drug Metabolism & Toxicology 2023; 19(12): 881 doi: 10.1080/17425255.2023.2292736
9
T. L. Manaenkova, T. A. Bairova, A. Yu. Sambyalova, A. I. Paramonov, E. V. Belyaeva, O. V. Bugun, L. V. Rychkova. Comorbid disease in children and adolescents with perinatal HIV infection: A pilot studyActa Biomedica Scientifica 2022; 7(5-2): 74 doi: 10.29413/ABS.2022-7.5-2.8
10
Nouhoum Bouare, Mamadou Keita, Jean Delwaide. Comment on review article: Chronic hepatitis C virus infection cascade of care in pediatric patientsWorld Journal of Gastroenterology 2022; 28(14): 1494-1498 doi: 10.3748/wjg.v28.i14.1494
11
Zixuan Feng, Qiushi Chen, Lirui Jiao, Xuedi Ma, Rifat Atun, Pascal Geldsetzer, Till Bärnighausen, Simiao Chen. The impact of health insurance on hypertension care: a household fixed effects study in IndiaBMC Public Health 2024; 24(1) doi: 10.1186/s12889-024-19759-1
12
Muhammad Abdel‐Gawad, Sherief Abd‐elsalam, Ibrahim Abdel‐Gawad, Mohammed Tag‐Adeen, Marwa El‐Sayed, Dalia Abdel‐Malek. Seroprevalence of hepatitis C virus infection in children: A systematic review and meta‐analysisLiver International 2022; 42(6): 1241 doi: 10.1111/liv.15212
13
Maria Pokorska-Śpiewak, Anna Dobrzeniecka, Agnieszka Ogrodnik. Efficacy and Safety of the Treatment of Chronic Hepatitis C with Sofosbuvir/Ledipasvir in Children Aged 5 to 10 Years with Comorbidities—A Brief ReportInfectious Disease Reports 2022; 14(4): 574 doi: 10.3390/idr14040061